Cargando…
A pilot study using metagenomic sequencing of the sputum microbiome suggests potential bacterial biomarkers for lung cancer
Lung cancer (LC) is the most prevalent cancer worldwide, and responsible for over 1.3 million deaths each year. Currently, LC has a low five year survival rates relative to other cancers, and thus, novel methods to screen for and diagnose malignancies are necessary to improve patient outcomes. Here,...
Autores principales: | Cameron, Simon J. S., Lewis, Keir E., Huws, Sharon A., Hegarty, Matthew J., Lewis, Paul D., Pachebat, Justin A., Mur, Luis A. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5444587/ https://www.ncbi.nlm.nih.gov/pubmed/28542458 http://dx.doi.org/10.1371/journal.pone.0177062 |
Ejemplares similares
-
Metagenomic Sequencing of the Chronic Obstructive Pulmonary Disease Upper Bronchial Tract Microbiome Reveals Functional Changes Associated with Disease Severity
por: Cameron, Simon J. S., et al.
Publicado: (2016) -
Lung cancer: a new frontier for microbiome research and clinical translation
por: Mur, Luis AJ, et al.
Publicado: (2018) -
Evaluation of FTIR Spectroscopy as a diagnostic tool for lung cancer using sputum
por: Lewis, Paul D, et al.
Publicado: (2010) -
Welcome to Animal Microbiome
por: Huws, Sharon A.
Publicado: (2019) -
Metaphylogenomic and Potential Functionality of the Limpet Patella pellucida’s Gastrointestinal Tract Microbiome
por: Dudek, Magda, et al.
Publicado: (2014)